Benjamin D Grant1, Chelsey A Smith2, Philip E Castle3, Michael E Scheurer4, Rebecca Richards-Kortum5. 1. Department of Bioengineering, Rice University, 6100 Main Street, Houston, TX 77005, United States. Electronic address: bgrant@intven.com. 2. Department of Bioengineering, Rice University, 6100 Main Street, Houston, TX 77005, United States. Electronic address: cas16@rice.edu. 3. Global Coalition Against Cervical Cancer, United States; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Block Room 341, Bronx, NY 10461, United States. Electronic address: castle.philip@gmail.com. 4. Department of Hematology/Oncology, Baylor College of Medicine, ABBR R517, MS: BCM305, Houston, TX 77030, United States. Electronic address: scheurer@bcm.edu. 5. Department of Bioengineering, Rice University, 6100 Main Street, Houston, TX 77005, United States. Electronic address: rkortum@rice.edu.
Abstract
OBJECTIVE: To develop and evaluate a paper-based point-of-care HPV serology test to determine if an individual has received two or more HPV immunizations. METHODS: The paper-based immunoassay was constructed using a nitrocellulose lateral flow strip with adsorbed HPV16 virus-like particles serving as the capturing moiety. Three capture zones containing virus-like particles were placed in series to allow for visual discrimination between high and low HPV16 plasma antibody concentrations. A plasma separation membrane was used to allow whole blood to be applied directly to the assay. All reagents were dried on glass fiber pads during device fabrication and were rehydrated with buffer at the time of use. A pilot study consisting of 35 subjects with a history of zero, one, two or three HPV vaccines was conducted to evaluate the immunoassay. The completed paper-based immunoassays were scanned for visual interpretation by three researchers who were blinded to the true results and separately evaluated quantitatively using MATLAB. RESULTS: For the 28 tests valid for analysis, fifteen subjects reported receiving two or more HPV vaccines, three reported receiving one, and ten reported having no HPV vaccinations. The paper-based immunoassays for all fifteen subjects who reported having received two or more HPV vaccines were judged positive by all researchers. Twelve of the thirteen tests from individuals reporting one or zero vaccinations were deemed negative by all observers. One test from an unvaccinated individual was judged positive by two out of three reviewers. Quantitatively, all tests were correctly separated between the two groups. CONCLUSIONS: We successfully designed and tested a HPV serology test amenable to the point-of-care. The device showed promising results in a pilot study for discriminating between those who received two or more HPV vaccinations and those who did not. Furthermore, this device offers a platform for producing other semi-quantitative point-of-care serological tests.
OBJECTIVE: To develop and evaluate a paper-based point-of-care HPV serology test to determine if an individual has received two or more HPV immunizations. METHODS: The paper-based immunoassay was constructed using a nitrocellulose lateral flow strip with adsorbed HPV16 virus-like particles serving as the capturing moiety. Three capture zones containing virus-like particles were placed in series to allow for visual discrimination between high and low HPV16 plasma antibody concentrations. A plasma separation membrane was used to allow whole blood to be applied directly to the assay. All reagents were dried on glass fiber pads during device fabrication and were rehydrated with buffer at the time of use. A pilot study consisting of 35 subjects with a history of zero, one, two or three HPV vaccines was conducted to evaluate the immunoassay. The completed paper-based immunoassays were scanned for visual interpretation by three researchers who were blinded to the true results and separately evaluated quantitatively using MATLAB. RESULTS: For the 28 tests valid for analysis, fifteen subjects reported receiving two or more HPV vaccines, three reported receiving one, and ten reported having no HPV vaccinations. The paper-based immunoassays for all fifteen subjects who reported having received two or more HPV vaccines were judged positive by all researchers. Twelve of the thirteen tests from individuals reporting one or zero vaccinations were deemed negative by all observers. One test from an unvaccinated individual was judged positive by two out of three reviewers. Quantitatively, all tests were correctly separated between the two groups. CONCLUSIONS: We successfully designed and tested a HPV serology test amenable to the point-of-care. The device showed promising results in a pilot study for discriminating between those who received two or more HPV vaccinations and those who did not. Furthermore, this device offers a platform for producing other semi-quantitative point-of-care serological tests.
Authors: Luisa L Villa; Kevin A Ault; Anna R Giuliano; Ronaldo L R Costa; Carlos A Petta; Rosires P Andrade; Darron R Brown; Alex Ferenczy; Diane M Harper; Laura A Koutsky; Robert J Kurman; Matti Lehtinen; Christian Malm; Sven-Eric Olsson; Brigitte M Ronnett; Finn Egil Skjeldestad; Margareta Steinwall; Mark H Stoler; Cosette M Wheeler; Frank J Taddeo; Jimmy Yu; Lisa Lupinacci; Radha Railkar; Rocio Marchese; Mark T Esser; Janine Bryan; Kathrin U Jansen; Heather L Sings; Gretchen M Tamms; Alfred J Saah; Eliav Barr Journal: Vaccine Date: 2006-05-15 Impact factor: 3.641
Authors: S J Rolnick; E D Parker; J D Nordin; B D Hedblom; F Wei; T Kerby; J M Jackson; A L Crain; G Euler Journal: Vaccine Date: 2013-06-24 Impact factor: 3.641
Authors: Joseph K Rotich; Terry J Hannan; Faye E Smith; John Bii; Wilson W Odero; Nguyen Vu; Burke W Mamlin; Joseph J Mamlin; Robert M Einterz; William M Tierney Journal: J Am Med Inform Assoc Date: 2003-03-28 Impact factor: 4.497
Authors: Elmar A Joura; Anna R Giuliano; Ole-Erik Iversen; Celine Bouchard; Constance Mao; Jesper Mehlsen; Edson D Moreira; Yuen Ngan; Lone Kjeld Petersen; Eduardo Lazcano-Ponce; Punnee Pitisuttithum; Jaime Alberto Restrepo; Gavin Stuart; Linn Woelber; Yuh Cheng Yang; Jack Cuzick; Suzanne M Garland; Warner Huh; Susanne K Kjaer; Oliver M Bautista; Ivan S F Chan; Joshua Chen; Richard Gesser; Erin Moeller; Michael Ritter; Scott Vuocolo; Alain Luxembourg Journal: N Engl J Med Date: 2015-02-19 Impact factor: 91.245
Authors: Hilary A Robbins; Troy J Kemp; Carolina Porras; Ana Cecilia Rodriguez; Mark Schiffman; Sholom Wacholder; Paula Gonzalez; John Schiller; Douglas Lowy; Sylviane Poncelet; Mark Esser; Katie Matys; Allan Hildesheim; Ligia A Pinto; Rolando Herrero; Mahboobeh Safaeian Journal: Front Oncol Date: 2014-01-13 Impact factor: 6.244
Authors: Neha Garg; Dylan Boyle; Arlo Randall; Andy Teng; Jozelyn Pablo; Xiaowu Liang; David Camerini; Abraham P Lee Journal: Lab Chip Date: 2019-04-23 Impact factor: 6.799
Authors: William Cherniak; Nikki Tyler; Kriti Arora; Ilana Lapidos-Salaiz; Emma Sczudlo; Amy Lin; Matthew Barnhart; John Flanigan; Shannon Silkensen Journal: Fam Med Community Health Date: 2019-10-31